Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Solicitation opportunity from New York was posted on March 7, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Chimeric antigen receptor (CAR) T-cell therapy system

Closed
2119753State & Local

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

This contract involves the procurement of a chimeric antigen receptor (CAR) T-cell therapy system supplied by Bristol Myers Squibb and distributed through US Oncology Inc, a subsidiary of McKesson Specialty Distribution. The award is designated as a single-source, sole-source procurement due to Bristol Myers Squibb being the exclusive recipient, and it is exempt from advertising requirements. The contract is specifically targeted for use within Onondaga County and is intended to support the healthcare needs of the region. The contract period runs from April 1, 2025, through March 31, 2028, with an estimated value ranging between 5 million and 20 million dollars. The solicitation for this contract was posted on March 7, 2025, with a response deadline of March 14, 2025. The contract is managed by the State University of New York (SUNY) under the New York State Office of General Services, with the primary contact being Michael Cushner, Hospital Purchase Associate. Interested parties can find additional details and respond via the NYS Contract Reporter website. This procurement aims to ensure access to advanced CAR T-cell therapy for eligible patients, supporting ongoing efforts to improve cancer treatment options within the state.

General Info

Place of Performance

NY, USA

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyState University of New York (SUNY)
Contacts1 person available
OfficeN/A
Office AddressN/A
Contacts
Michael CushnerHospital Purchase Associate

Full Description

Show more
Chimeric antigen receptor (CAR) T-cell therapy system from Bristol Myers Squibb and distributed from US Oncology Inc a subsidiary of McKesson Specialty Distribution. Reason for advertising exemption: Single Source Award recipient: Bristol Myers Squibb via US Oncology Inc Any questions or comments regarding this notice of sole-source, single-source, or procurement otherwise exempt from advertising in the NYS Contract Reporter should be directed to the contact person listed for the contracting agency or public authority. Ad end date:03/14/2025 Contract term: 4/1/25-3/31/28 County(ies): Onondaga

More opportunities from State University of New York (SUNY)

Same awarding agency

Earlier notices in this NAICS code

Posted before this notice, open and closed

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS